02/20/19: Meghana Keshavan published an article, done in collaboration with patients from the BCAN community, on Stat. To read the article, please follow this link. The article highlights some of the challenges that patients and doctors face during this BCG shortage.
The John Quale Travel Fellowship Program provides funding to defray travel-related costs for up to eight early career investigators with a demonstrated interested in bladder cancer research to attend the annual Bladder Cancer Think Tank Meeting, a unique opportunity to meet and learn from leaders in the field. The primary
Bethesda, MD – The Bladder Cancer Advocacy Network (BCAN) is pleased to announce our 2019 Travel Fellowship which is awarded to early career physicians and scientists interested in attending the Bladder Cancer Think Tank, August 8-10, 2019. Hosted by the BCAN, the mission of the Think Tank is to enhance
Many friends of BCAN are choosing to leave a lasting legacy by making a gift through their will or estate. Some of the largest gifts we’ve received — the kind that really make a difference for future generations — come from planned gifts. You can give many kinds of assets
According to the American Cancer Society the death rate from cancer in the United States has declined steadily over the past 25 years. Lower cancer mortality rates may be due to steady reductions in smoking and advances in early detection and treatment. Yet despite that, bladder cancer remains the sixth
Our “Conversations: Let’s Talk About Bladder Cancer” video series provides valuable, comprehensive insight on key treatment and quality of life issues for bladder cancer patients, caregivers, family members, and friends. BCAN Co-Founder Diane Zipursky Quale engages experts with questions that patients and caregivers may be reluctant to ask about important
The Bladder Cancer Advocacy Network (BCAN) is pleased to announce two 2019 Young Investigator Awards *(YIA), to support the development of outstanding early career research scientists and clinical cancer research investigators who have demonstrated a commitment to improving the understanding and treatment of bladder cancer. In addition, BCAN is designating an